US 6828416
Recombinant multivalent malarial vaccine against Plasmodium falciparum
expired A61KA61K39/00A61P
Quick answer
US patent 6828416 (Recombinant multivalent malarial vaccine against Plasmodium falciparum) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Dec 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Dec 07 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K39/00, A61P, A61P33/02, A61P33/06